Cambridge Investment Research Advisors
CSII

Cambridge Investment Research Advisors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,694
Closed -$337K – 2628
2020
Q2 		$337K Sell
10,694
-1,170
-10% -$43.7K ﹤0.01% 1794
2020
Q1 		$418K Sell
11,864
-3,765
-24% -$159K ﹤0.01% 1476
2019
Q4 		$759K Sell
15,629
-2,436
-13% -$111K 0.01% 1316
2019
Q3 		$858K Buy
18,065
+2,615
+17% +$123K 0.01% 1158
2019
Q2 		$663K Hold
15,450
– – 0.01% 1265
2019
Q1 		$597K Hold
15,450
– – 0.01% 1370
2018
Q4 		$440K Buy
15,450
+100
+0.7% +$3.18K ﹤0.01% 1400
2018
Q3 		$601K Sell
15,350
-2,568
-14% -$94.9K 0.01% 1342
2018
Q2 		$579K Sell
17,918
-4,667
-21% -$128K 0.01% 1324
2018
Q1 		$495K Buy
22,585
+250
+1% +$6.01K 0.01% 1359
2017
Q4 		$529K Sell
22,335
-1,750
-7% -$44.1K 0.01% 1294
2017
Q3 		$678K Buy
24,085
+500
+2% +$15.2K 0.01% 1044
2017
Q2 		$760K Buy
23,585
+8,255
+54% +$252K 0.01% 953
2017
Q1 		$433K Sell
15,330
-2,711
-15% -$72K 0.01% 1150
2016
Q4 		$437K Hold
18,041
– – 0.01% 1075
2016
Q3 		$428K Sell
18,041
-37
-0.2% -$810 0.01% 1120
2016
Q2 		$332K Hold
18,078
– – 0.01% 1131
2016
Q1 		$187K Hold
18,078
– – ﹤0.01% 1413
2015
Q4 		$273K Hold
18,078
– – 0.01% 1171
2015
Q3 		$286K Hold
18,078
– – 0.01% 1045
2015
Q2 		$478K Sell
18,078
-2,719
-13% -$87.8K 0.01% 827
2015
Q1 		$812K Sell
20,797
-9,868
-32% -$340K 0.02% 589
2014
Q4 		$922K Hold
30,665
– – 0.03% 520
2014
Q3 		$725K Buy
30,665
+392
+1% +$11.2K 0.02% 638
2014
Q2 		$943K Buy
30,273
+100
+0.3% +$2.88K 0.03% 476
2014
Q1 		$959K Sell
30,173
-6,712
-18% -$222K 0.04% 436
2013
Q4 		$1.26M Sell
36,885
-15,320
-29% -$446K 0.05% 330
2013
Q3 		$1.05M Buy
52,205
+1,000
+2% +$20.8K 0.05% 350
2013
Q2 		$1.09M Buy
+51,205
New +$995K 0.06% 305

Other funds holding CSII

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Cambridge Investment Research Advisors's CSII Position: Q3 2020 in Review

Cambridge Investment Research Advisors sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2020, closing a stake of 10,694 shares — an estimated $337K sold.

Cambridge Investment Research Advisors first reported a position in CSII in Q2 2013 and held it in 29 quarters. The position peaked at $1.26M in Q4 2013. 186 funds tracked by Wall St. Rank hold CSII as of Q3 2020.

  • Cambridge Investment Research Advisors reported no remaining Cardiovascular Systems, Inc. position as of Q3 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,694 Cardiovascular Systems, Inc. shares in Q3 2020, an estimated $337K.
  • Cambridge Investment Research Advisors first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 29 quarters.
  • Cambridge Investment Research Advisors's Cardiovascular Systems, Inc. position peaked at $1.26M in Q4 2013.
  • 186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.